<DOC>
	<DOCNO>NCT02310347</DOCNO>
	<brief_summary>The purpose study examine influence medicinal cannabinoid agonist versus placebo behavioural gut peptide responses food image food intake .</brief_summary>
	<brief_title>Influence Medicinal Cannabinoid Agonist Responses Food Images Food Intake</brief_title>
	<detailed_description />
	<mesh_term>Dronabinol</mesh_term>
	<mesh_term>Cannabinoid Receptor Agonists</mesh_term>
	<criteria>For healthy volunteer : 1 . 20 ≤ BMI ≤ 25 2 . Age 1860 3 . Right hand 4 . Stable body weight least 3 consecutive month start study history behavioural , therapeutic surgical treatment aim lead weight loss/gain For obese subject : 1 . BMI &gt; 30 2 . Age 1860 3 . Right hand 4 . Stable body weight least 3 consecutive month start study behavioural , therapeutic surgical treatment aim lead weight loss/gain least 3 consecutive month For FD patient : 1 . FD diagnosis accord 'Rome III ' criterion 2 . Age 1860 3 . Right hand 4 . 5 % weight loss since onset symptom 1 . Medical condition ( current history ) : Abdominal/thoracic surgery except appendectomy Gastrointestinal , endocrine ( especially diabetes ) , neurological disease Cardiovascular , respiratory , renal urinary disease Hypertension Food drug allergy Head trauma loss consciousness 2 . Psychiatric disorder : Eating disorder Psychotic disorder Major depressive disorder Somatoform disorder 3 . Medication use : No history cannabis use drug abuse least 12 month prior study All medication except oral contraception ; 4 . Known allergy dronabinol and/or sesam oil 5 . Pregnancy , plan conceive refusal take adequate precaution avoid pregnancy 6 . Subjects refuse abstain drive study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>